DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Aitchison M, Bray C, van Poppel H, Sylvester R, Graham J, Innes C, McMahon L, Vasey PA.
Preliminary results from a randomized phase III trial of
adjuvant interleukin-2, interferon alpha and 5-fluorouracil in patients with a
high risk of relapse after nephrectomy for renal cell carcinoma (RCC).
J Clin Oncol 2008; 26
We do not assume any responsibility for the contents of the web pages of other providers.